German Pharmaceuticals & Biotech Potentially Undervalued Companies

Spectrum Pharmaceuticals

Market Cap: €209.9m

Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology drug products.

Grand Pharmaceutical Group

Market Cap: €18.6b

An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.

Regeneron Pharmaceuticals

Market Cap: €68.4b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide.

Perrigo

Market Cap: €1.5b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

Indivior Pharmaceuticals

Market Cap: €4.8b

Engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.

Prestige Consumer Healthcare

Market Cap: €2.4b

Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.

Faes Farma

Market Cap: €1.4b

Researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally.

Regeneron Pharmaceuticals

Market Cap: €68.4b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide.

United Laboratories International Holdings

Market Cap: €18.1b

An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.

Virbac

Market Cap: €2.9b

Manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Pacific.

3SBio

Market Cap: €42.3b

An investment holding company, engages in the development, production, marketing, and sale of biopharmaceutical products in the People’s Republic of China, the United States, and internationally.

Danaher

Market Cap: €142.3b

Designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.

Bavarian Nordic

Market Cap: €13.8b

Develops, manufactures, and supplies life-saving vaccines.

ANI Pharmaceuticals

Market Cap: €1.6b

A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.

Trajan Group Holdings

Market Cap: €32.0m

Develops, manufactures, and sells analytical and life science products and devices in Malaysia, Japan, Australia, New Zealand, the United States, Europe, the Middle East, Africa, and India.

Cresco Labs

Market Cap: €458.7m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.

China Medical System Holdings

Market Cap: €30.4b

An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.

China Resources Pharmaceutical Group

Market Cap: €30.0b

An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.

Danaher

Market Cap: €142.3b

Designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.

Fine Foods & Pharmaceuticals N.T.M

Market Cap: €203.7m

Fine Foods & Pharmaceuticals N.T.M. S.p.A.

CorMedix

Market Cap: €610.4m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

Consun Pharmaceutical Group

Market Cap: €11.4b

Produces and sells pharmaceutical products in Mainland China.

Dermapharm Holding

Market Cap: €2.1b

Manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China.

High Tide

Market Cap: €268.9m

Engages in the cannabis retail business in Canada, the United States, and internationally.

Vetoquinol

Market Cap: €834.5m

A veterinary pharmaceutical company, engages in designing, developing, and selling of veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region.

Dermapharm Holding

Market Cap: €2.1b

Manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China.

Bavarian Nordic

Market Cap: €13.8b

Develops, manufactures, and supplies life-saving vaccines.

Goodbody Health

Market Cap: €1.3m

Goodbody Health Inc., a wellness company, provides health and wellness range of products and services in the United Kingdom.

Gossamer Bio

Market Cap: €68.9m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States.

TerrAscend

Market Cap: €294.7m

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.

Agenus

Market Cap: €207.0m

A clinical-stage biotechnology company, discovers and develops immunotherapies for cancer and infectious diseases in the United States and internationally.

Daiichi Sankyo Company

Market Cap: €5.0t

Manufactures and sells pharmaceutical products in Japan and internationally.

ACADIA Pharmaceuticals

Market Cap: €4.3b

A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.

Protara Therapeutics

Market Cap: €228.8m

A clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases.

Sanofi

Market Cap: €92.3b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

Joincare Pharmaceutical Group IndustryLtd

Market Cap: €18.5b

Joincare Pharmaceutical Group Industry Co.,Ltd.